GE HealthCare Technologies Inc. (NASDAQ:GEHC) Position Raised by Burford Brothers Inc.

Burford Brothers Inc. raised its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 8.2% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 5,157 shares of the company’s stock after buying an additional 391 shares during the quarter. Burford Brothers Inc.’s holdings in GE HealthCare Technologies were worth $484,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently added to or reduced their stakes in the stock. Pathway Financial Advisers LLC bought a new stake in shares of GE HealthCare Technologies during the first quarter valued at about $25,000. Fred Alger Management LLC bought a new stake in shares of GE HealthCare Technologies during the second quarter valued at about $26,000. BNP Paribas bought a new stake in shares of GE HealthCare Technologies during the first quarter valued at about $30,000. Elkhorn Partners Limited Partnership bought a new stake in shares of GE HealthCare Technologies during the second quarter valued at about $31,000. Finally, Annapolis Financial Services LLC raised its stake in shares of GE HealthCare Technologies by 171.9% during the first quarter. Annapolis Financial Services LLC now owns 348 shares of the company’s stock valued at $32,000 after purchasing an additional 220 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other GE HealthCare Technologies news, CEO Thomas J. Westrick sold 2,750 shares of the stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total transaction of $222,145.00. Following the completion of the transaction, the chief executive officer now directly owns 17,509 shares in the company, valued at $1,414,377.02. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 0.27% of the company’s stock.

Analysts Set New Price Targets

GEHC has been the topic of a number of research reports. Redburn Atlantic upgraded GE HealthCare Technologies to a “strong-buy” rating in a report on Thursday, August 1st. BTIG Research upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price objective on the stock in a report on Wednesday, September 18th. Evercore ISI increased their price objective on GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an “outperform” rating in a report on Tuesday, October 1st. Stifel Nicolaus increased their price objective on GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a “buy” rating in a report on Monday, September 30th. Finally, UBS Group cut GE HealthCare Technologies from a “neutral” rating to a “sell” rating and decreased their target price for the stock from $84.00 to $74.00 in a research report on Thursday, September 26th. One analyst has rated the stock with a sell rating, five have given a hold rating, seven have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $94.23.

GE HealthCare Technologies Stock Down 0.5 %

Shares of GEHC stock opened at $88.42 on Friday. The stock has a market cap of $40.36 billion, a P/E ratio of 25.85, a price-to-earnings-growth ratio of 3.39 and a beta of 1.18. GE HealthCare Technologies Inc. has a one year low of $62.35 and a one year high of $94.55. The stock has a fifty day moving average price of $88.42 and a 200 day moving average price of $83.45. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.06 and a quick ratio of 0.82.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, July 31st. The company reported $1.00 EPS for the quarter, topping the consensus estimate of $0.98 by $0.02. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The firm had revenue of $4.84 billion during the quarter, compared to analysts’ expectations of $4.88 billion. During the same period last year, the business earned $0.92 earnings per share. GE HealthCare Technologies’s quarterly revenue was up .5% compared to the same quarter last year. Analysts predict that GE HealthCare Technologies Inc. will post 4.26 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be paid a dividend of $0.03 per share. The ex-dividend date is Friday, October 18th. This represents a $0.12 annualized dividend and a yield of 0.14%. GE HealthCare Technologies’s dividend payout ratio is currently 3.51%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.